The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
Medscape Medical News > Conference News
December 21, 2023
A key to a ‘faulty’ lock: Why Aussie researchers are excited about naltrexone for CFS
Ausdoc.com
31 July 2023
https://www.ausdoc.com.au/news/a-key-to-a-faulty-lock-why-aussie-researchers-are-excited-about-naltrexone-for-cfs/
Off-Label Meds: Promising Long COVID Treatments?
Medscape
28 July 2023
https://www.medscape.com/viewarticle/994728?form=fpf
With a lack of FDA-approved treatments, doctors who treat long COVID are turning to off-label use of drugs designed for addiction, diabetes, and other conditions.The FDA approves each drug to treat a specific condition. Off-label use, which is legal and common, allows doctors to prescribe drugs for another use.
Queensland scientists push for new national treatment guidelines for chronic fatigue syndrome
ABC News
12 June 2023
https://www.abc.net.au/news/2023-06-13/griffith-university-scientists-researching-chronic-fatigue-mecfs/102471386
Largest medical research grant to help ME/CFS and Long COVID research
Griffith News
19 April 2023
https://news.griffith.edu.au/2023/04/19/largest-medical-research-grant-to-help-me-cfs-and-long-covid-research/
Treating Long-COVID Brain Fog With ME/CFS Guidelines
Medscape
27 March 2023
https://www.medscape.com/viewarticle/989887
Cognitive symptoms, commonly referred to as brain fog, are among the most common persistent or new symptoms after COVID-19. Cognitive symptoms are also often reported by patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).